NorthWest Biotherapeutics Inc (NWBO)

[AllSheWrote]

Yeah, I have some thoughts. It's not getting approved. There wasn't a third RFI, or a second RFI. The decision is not back in MHRA's hands because MHRA has no response to consider. NWBIO cannot respond to the first RFI, which asked them to provide patient-level data from the ECAs. All my opinion of course, but it really is that simple. You know it, too. Why would you deny that this is obviously the most likely scenario?